Dr. Peter GK Mathen, M.D.
Claim this profileClinical Trials Peter GK Mathen, M.D. is currently running
More about Peter GK Mathen, M.D.
Clinical Trial Related
1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Peter GK Mathen, M.D. has experience with
- Hypofractionation Trial Of Re-irradiation
Breakdown of trials Peter GK Mathen, M.D. has run
Protoplasmic Astrocytoma
Brain Tumor
Glioblastoma
Astrocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter GK Mathen, M.D. specialize in?
Peter GK Mathen, M.D. focuses on Protoplasmic Astrocytoma and Brain Tumor. In particular, much of their work with Protoplasmic Astrocytoma has involved treating patients, or patients who are undergoing treatment.
Is Peter GK Mathen, M.D. currently recruiting for clinical trials?
Yes, Peter GK Mathen, M.D. is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Peter GK Mathen, M.D. has studied deeply?
Yes, Peter GK Mathen, M.D. has studied treatments such as Hypofractionation Trial of Re-irradiation.
What is the best way to schedule an appointment with Peter GK Mathen, M.D.?
Apply for one of the trials that Peter GK Mathen, M.D. is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.